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Abstract
Background: Previous studies have demonstrated that individual measures of fitness – such as reduced pulmonary
function, slow walking speed and weak handgrip – are associated with an increased risk of dementia. Only a
minority of participants included in these studies were aged over 80. The aim of this study was therefore to
investigate the association between physical fitness and dementia in the oldest old.
Methods: Subjects (n = 488) were enrolled in the Lothian Birth Cohort 1921 and aged 79 at baseline. Dementia
cases arising after enrolment were determined using data from death certificates, electronic patient records and
clinical reviews. Fitness measures included grip strength, forced expiratory volume in 1 s (FEV1) and walking speed
over 6 m, measured at 79 years. Dementia risk associated with each fitness variable was initially determined by
logistic regression analysis, followed by Cox regression analysis, where death was considered as a competing risk.
APOE ε4 status, age, sex, height, childhood IQ, smoking, history of cardiovascular or cerebrovascular disease,
hypertension and diabetes were included as additional variables. Cumulative incidence graphs were calculated
using Aalen-Johansen Estimator.
Results: Although initial results indicated that greater FEV1 was associated with an increased risk of dementia (OR
(odds ratio per unit increase) 1.93, p = 0.03, n = 416), taking into account the competing risk of mortality, none of
the fitness measures were found to be associated with dementia; FEV1 (HR (hazard ratio per unit increase) 1.30, p = 0.37,
n = 416), grip strength (HR 0.98, p = 0.35, n = 416), walking speed (HR 0.99, p = 0.90, n = 416). The presence of an APOE ɛ4
allele was however an important predictor for dementia (HR 2.85, p < 0.001, n = 416). Cumulative incidence graphs
supported these findings, with an increased risk of dementia for APOE ɛ4 carriers compared with non-carriers. While
increased FEV1 was associated with reduced risk of death, there was no reduction in risk for dementia.
Conclusions: In contrast to previous studies, this study found that lower fitness beyond age 79 was not a risk factor for
subsequent dementia. This finding is not explained by those with poorer physical fitness, who would have been more
likely to develop dementia, having died before onset of dementia symptoms.
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Background
Overall physical fitness may be considered as the capacity
of an individual’s body to undertake varying degrees of
physical activity. As such, physical fitness can reflect a per-
son’s ability to undertake the physical activities required to
achieve day-to-day function. Overall physical fitness is
comprised of a number of factors; the most important of
which are probably muscular strength, muscular endur-
ance, and cardiorespiratory or cardiovascular endurance.
In the investigation of associations between fitness and
disease, test measures should therefore reflect at least one
of these components. Within the literature, tests of lung
function, walking speed and grip strength are frequently
used to measure physical fitness. Such measures reflect
the components of physical fitness described above, with
lung function tests providing a measure of cardiorespira-
tory function, grip strength providing a measure of mus-
cular strength and walking speed providing a measure of
both muscular endurance and cardiorespiratory endur-
ance. A latent trait representing physical fitness can be
extracted from these variables which is significantly
associated with non-pathological cognitive change in this
cohort of older adults at age ~ 80 years [1].
By examining the relationship between such physical
fitness measures and disease, studies can determine
whether fitness levels may be considered as a risk factor
for disease. With widely recognised risk factors for
dementia – such as age and APOE ε4 allele status – be-
ing fixed and unchangeable, identifying potentially modi-
fiable risk factors would be of considerable value in
contributing to the development of strategies aimed at
reducing disease incidence. Such strategies are of par-
ticular importance in dementia, given the lack of cure or
universally effective treatments. Several previous studies
have therefore explored the potential association be-
tween physical fitness and dementia. Such studies have
demonstrated that reduced pulmonary function [2–8],
slow walking speed [9–13] and weak handgrip [9, 10, 14,
15] are associated with an increased risk of dementia.
One might hypothesise that these findings reflect the
importance of maintaining an optimal blood supply to
the brain [16]. Specifically, if an individual has poor lung
function, it is possible that blood oxygenation levels are
below those required to maintain brain health. Further-
more, slow walking speed may be due to cardiovascular
deficiencies and if the heart and circulatory system are
struggling to meet the requirements of other areas of
the body, it is possible that the brain is experiencing
similar deficiencies. While none of these deficiencies
may be dramatic enough to result in immediate clinical
concern, it is possible that slight inadequacies that are
present over a period of time could result in changes to
brain structure or function. It is also possible that with
increased fitness comes a reduction in other potential
risk factors for dementia, such as hypertension, diabetes
and increased body mass index [16]. The documented
association between physical fitness and normal cogni-
tive ageing [1], together with evidence that physical
activity – which correlates with physical fitness – is a
risk factor for dementia in generally younger populations
[17], suggests that there is good a priori rationale to
investigate whether such risk persists into the ninth
decade and beyond.
Only a minority of participants included in the afore-
mentioned studies were aged over 80 years. Those studies
with an older mean participant age may involve partici-
pants from a wide age range (for example: mean age
80.3 years, age range 54–100 years) [14] and it is not
therefore possible to draw any inferences regarding the
relationship between fitness and dementia in oldest age
given the potential influence of those younger participants
included in the analyses. Based on current evidence, it
remains unclear whether the patterns of association iden-
tified in early old age persist into oldest age. Within the
literature, studies looking specifically at the oldest-old are
typically fewer in number, likely as the result of difficulties
in recruitment and retention of study participants, for
reasons including co-morbidity and mortality. Under-
standing how the risk factor profile for dementia changes
with age is vital in designing successful preventative strat-
egies. In 2017, the number of persons aged 79 years or
older in the UK was estimated to be 3,635,993; 5.5% of the
total population [18]. As life expectancy increases and the
global population ages, the number of persons reaching
oldest-age are expected to grow, reinforcing the import-
ance of understanding patterns of disease in this growing
section of the population through further research.
This study considers the participants of the Lothian
Birth Cohort 1921 (LBC1921), who were recruited at age
79 years and have undergone follow-up for dementia
into their 90s. While a previous study of the LBC1921
had identified an association between superior physical
fitness at age 79 years and improved cognitive aging [1],
the effect of fitness at age 79 years on the development
of dementia had not been investigated in this cohort.
Measures of fitness collected at baseline (grip strength,
time to walk 6 m and forced expiratory volume in 1 s
(FEV1)) reflected those commonly used within the litera-
ture and would therefore allow for comparisons with
previous findings. As such, the study of physical fitness
measures and dementia within this detailed, narrow-age
cohort would be well-suited to add evidence, specific to
the oldest-old, to the literature. Given the frequency of
death within a cohort of advanced age we recognised the
possibility that this may influence our findings. Such
consideration was particularly important given that asso-
ciations between reduced grip strength, reduced pul-
monary function, reduced walking speed and increased
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risk of death have been well documented [19, 20]. We
therefore planned to consider death as a competing risk
in our analyses.
The primary aim of this study was therefore to explore
the association between three measures of physical fit-
ness – grip strength, lung function and walking speed –
and subsequent dementia in persons aged over 79 years.
Methods
Participants
Participants were members of the Lothian Birth Cohort
1921 (LBC1921), which is described more fully else-
where [21]. Most had taken part in general intelligence
testing at age 11, as part of the Scottish Mental Survey
1932 (SMS1932) [22]. Childhood cognitive test scores
were available for 89.6% of those LBC1921 participants
who attended baseline testing. Missing childhood cogni-
tive data was likely to have resulted from school absence
on the day of testing (due to sickness, for example), or
be because the test results for some schools in Fife (a re-
gion neighbouring Lothian) were not found. From 1999,
SMS1932 participants were traced and recruited for
follow-up in later life, with the aim of investigating
normal cognitive ageing [23]. Five-hundred and fifty
participants, mostly from the Lothian area of Scotland,
enrolled in the study and attended the first wave of test-
ing. Participants were aged approximately 79 years at
baseline. Surviving participants who continued to take
part in the study were re-tested at four subsequent test
waves; at ~ 83, 87, 90 and 92 years of age (approximately
3-yearly intervals). This interval was planned as the
period over which the authors expected to be able to
detect significant changes in some cognitive test scores,
while balancing this against attrition. At each wave, data
were collected by questionnaire and in-person testing.
Participant deaths were ascertained prospectively, at
regular intervals, with details supplied by the General
Registrar’s Office, Scotland. The Lothian Research Ethics
Committee (test waves 1–3) and the Scotland A
Research Ethics Committee (test waves 4–5) provided
ethical approval for the study. From wave 4, attending
participants provided consent for data linkage and access
to health records.
Fitness variables
The three fitness measures included in this study were
6-m walk time, grip strength and forced expiratory vol-
ume in 1 s (FEV1) [1]. Walking speed, grip strength and
FEV1 have all been shown to be valuable in evaluating
physical and functional capacity [24–27]. Six-metre walk
time was taken as the time in seconds for a participant
to walk a measured length of 6 m, at a normal walking
pace. Subjects were permitted to utilise any habitually
used walking aid, while those who were unable to walk
six metres would not participate in the test. A Jamar
Hydraulic Hand Dynamometer was used to measure grip
strength in kilograms, in the dominant hand; the best of
three trials was recorded. FEV1 was measured using a
microspirometer, in units of litres per second; the best of
three attempts was recorded. Taking three measure-
ments is in line with guidance for clinical practice [28].
Additional variables
The analyses would also include variables deemed to be
of potential importance with regard to their association
with either physical fitness or dementia. In a previous
study of the risk factors for dementia in LBC1921, posi-
tive APOE ɛ4 carrier status was found to increase risk,
whereas a history of hypertension was found to reduce
risk [29]. These variables were therefore included, along
with the following important control variables: age, sex,
height, age 11 IQ, smoking status, history of cardiovas-
cular or cerebrovascular disease and history of diabetes.
Age, sex and height are all key control variables given
the direct impact on physical strength and fitness.
Similarly, a history of cardiovascular or cerebrovascular
disease and diabetes history were included given the po-
tential association with physical fitness and dementia.
When such conditions impact a person’s ability to par-
take in exercise, fitness is likely to be adversely affected.
The inclusion of age 11 IQ as a control variable is im-
portant given the known association with dementia [30]
and other fitness-related factors [1, 31]. We also consid-
ered the potential impact of smoking status given the
likely association with physical fitness, and lung function
in particular. Whilst other factors were potentially asso-
ciated with fitness, we could not include all possible risk
factors, as this would have led to multiple hypotheses
testing. We therefore adopted the hypothesis-driven
approach described above, based on previous findings.
Data collection procedures
APOE ɛ4 status was determined using genomic DNA
isolated from participants’ venous blood. Any history of
hypertension, diabetes, cerebrovascular or cardiovascular
disease, smoking status (ex-, current-, or never-) and sex
were self-reported by participants at the first wave of
testing. A positive history of cerebrovascular or cardio-
vascular disease included those reporting previous
stroke, transient ischaemic attack, myocardial infarction,
angina, coronary artery bypass graft and angioplasty pro-
cedures and those who reported a positive history but
did not specify the specific nature. A positive history of
diabetes included those reporting any history of diabetes
(any type or type unspecified). Age at baseline was taken
from the number of days between date of birth and date
of attendance at wave 1 testing. Age 11 IQ was calcu-
lated based on the results of the Moray House Test
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(MHT) no.12, the general intelligence test taken by par-
ticipants at age 11 as part of SMS1932 [21]. MHT scores
were corrected for age at testing, then converted to
IQ-type scores with a standardised mean score of 100
(SD 15). Height in centimetres was measured using a
SECA stadiometer.
Dementia ascertainment
Follow-up for the purpose of dementia ascertainment
has been described previously and involved the retro-
spective collection of evidence, from enrolment to age
95 years [29]. Data were collected from death certifi-
cates, electronic hospital records, and clinical reviews.
Each death record available by 30th June 2016 was ex-
amined for evidence of dementia or cognitive impair-
ment. Electronic hospital records and psychiatric
records were accessed for participants who were willing
and able to consent to data linkage. Any evidence for de-
mentia or cognitive impairment since enrolment in the
study – whether a confirmed diagnosis or evidence for a
diagnosis – was recorded. Data were collected from elec-
tronic medical records to the 16th May 2016. Additional
information was available for 26 participants who under-
went clinical review by the authors (TCR, JMS), either in
the NHS or research setting. Information from such re-
views was collected up to 15th December 2016, when all
of the evidence from each source was considered at a
final dementia diagnosis consensus meeting (RAS, TCR,
JMS). The evidence was examined against a previously
described list of criteria for ‘probable’ or ‘possible’ de-
mentia diagnosis [29]. Using these criteria, the meeting
agreed upon the presence of a diagnosis and the subtype.
Any disagreement was resolved through discussion.
Event variables
The events considered in these analyses would be de-
mentia and death. Determination of these outcomes was
as described above. Time to death was taken as the
number of days between the date of attendance at wave
1 testing and date of death. For those who did not die,
the censoring time was taken as the number of days
between wave 1 testing and a date beyond that last date
of data collection for any participant. Time to dementia
was taken as the number of days between the date of
attendance at wave 1 testing and the first date that a
dementia diagnosis was noted in any of the available
sources. If dementia was recorded on a death certificate
only, and no duration was noted, the diagnosis was pre-
sumed to predate death by 6 months. If the duration
was not given on the death certificate, but a diagnosis
was recorded in another source, the earliest such date
was used to determine the time to dementia. If sources
had recorded cognitive decline, mild cognitive impair-
ment and dementia, the date was taken as the earliest
recording of a dementia diagnosis. If dementia was
ascertained based on evidence within the records that
did not include a formal diagnosis of dementia, the earli-
est mention of cognitive impairment was used to date
dementia (as long as this did not specifically note the
absence of a dementia syndrome). For those who did not
develop dementia, the time to dementia variable was
recorded as either the time to date of death or to a date
beyond that last date of data collection for any surviving
participant.
Participant exclusions
Any participant reporting a history of dementia or scoring
23 or less on the Folstein Mini Mental State Examination
[32] (MMSE) at baseline was excluded from our analyses.
Those without a valid MMSE score at baseline were also
excluded, as were those without any follow-up data avail-
able. To minimise the potential for classification error,
possible dementia cases were excluded from the analyses
and probable dementia was used as the primary outcome
in this study.
Statistical analysis
We first performed simple comparison analyses between
the group who developed dementia and the group who
did not, for each of the included variables. Univariate ana-
lyses were completed using either a Pearson chi-square
(for categorical variables) or independent samples t-test
(for continuous variables) (IBM SPSS, Version 21). A p
value of < 0.05 was used to demonstrate a statistically
significant difference. All subsequent steps in the analyses
were completed using the R statistical software (version
3.3.3) [33].
The second stage of the analyses used binary logistic
regression to examine the potential risks for dementia
associated with the fitness measures. In a first model (lo-
gistic regression model 1) we included the fitness vari-
ables along with those factors known to be associated
with dementia in our cohort and the other important
control variables (FEV1, grip strength, 6-m walk time,
APOE ɛ4 carrier status, height, age, sex, history of hyper-
tension, smoking status and age 11 IQ). The develop-
ment of probable dementia was the outcome. In the
second model (logistic regression model 2), the same
variables were included, with the addition of a history of
cardiovascular or cerebrovascular disease and a history
of diabetes. A history of hypertension was considered
separately to these other health variables as a statistically
significant association with dementia had previously
been observed within this cohort.
The main analyses used Cox regression models with
death being included as a competing risk for dementia;
in doing so, the influence of fitness on earlier death in
the analysis of dementia development due to fitness was
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considered. The models were completed using standard
software for Cox regression with right-censored data
and treating death as censored, (R package survival).
The first and second Cox regression models (Cox regres-
sion models 1 and 2) included the same covariates as
those described for logistic regression models 1 and 2.
Both models fitted the data acceptably with concordance
of 64%. Analysis of the scaled Schoenfeld residuals (R
function cox.zph), showed all covariates complied with
the proportional hazards assumption. As is recommended
practice, we supported the results of Cox regression with
graphs demonstrating cumulative incidence for each com-
peting event; illustrating the time-varying risk of dementia,
between covariate levels. The unbiased estimate of cumu-
lative incidence was calculated using the Aalen-Johansen
estimator [34], (R packages prodlim and mstate).
Results
Participant eligibility
A total of N = 550 participants recruited to LBC1921
attended baseline testing at age 79 years. We excluded
the following participants from the analyses: participants
with an MMSE score of less than 24 at baseline (n = 9),
participants without a valid MMSE score at baseline
(n = 2), participants reporting a history of dementia at
baseline (n = 2), and participants with no follow-up
data available for the purpose of dementia ascertainment
(n = 41). One additional participant was excluded as the
calculated time to dementia suggested that dementia pre-
dated attendance at wave 1 testing. From the remaining
participants (n = 495), a consensus diagnosis of probable
dementia was agreed for n = 109. Those participants with
a possible diagnosis of dementia were excluded from the
analyses (n = 7).
Participant demographics (Table 1)
The resulting eligible cohort (n = 488) included 280
females (57.4%) and 419 participants (85.9%) were
known to be deceased [29]. This included 331 who died
with no diagnosis of dementia. Descriptive statistics for
those eligible for inclusion (both with and without
dementia), and those excluded are shown in Table 1.
Event variables
The mean time to death for the n = 419 participants who
were known to be deceased was 3144.5 days (SD:
1517.5). For those who survived, the time to death was
taken as an arbitrary point beyond the last date of data
collection for any participant; 6500 days. The mean time
to dementia for the n = 109 who developed dementia
was 3535.7 days (SD: 1283.3). A total of n = 379 partici-
pants remained dementia free; for these participants,
time to dementia was taken either as the time to death
for those who died (n = 331, mean = 2863.0 days, SD:
1469.4), or an arbitrary point beyond the last date of
data collection for any participant (n = 48, 6500 days).
Dementia group comparison (Table 1)
Also included in Table 1 are the results of the group
comparison analyses. Univariate analyses demonstrated
little difference between those participants who devel-
oped dementia and those who did not. Only smoking
status (p < 0.001) and APOE ɛ4 (p < 0.001) carrier status
demonstrated statistically significant difference (p < 0.05).
Univariate analyses were also performed to compare
those who died with those who survived. Lower FEV1
and greater 6-m walk time were both associated with an
increased risk of death (p = 0.02 and p = 0.01, respect-
ively). The results for these univariate analyses are avail-
able in Additional file 1: Table S1.
Logistic regression results (Table 2)
The results of both logistic regression analyses demon-
strated that APOE ɛ4 remains an important risk factor
for dementia after age 79 years (logistic regression model
2: Odds Ratio (OR) 2.52 (95% confidence interval: 1.50,
4.22), p < 0.001). Both initial models also suggested that
increased FEV1 at age 79 increased the risk for subse-
quent dementia (logistic regression model 2: OR 1.93
(1.07, 3.57), p = 0.03). The only other variable that
reached statistical significance was height, and only in
the second model; increased height was shown to
decrease risk for subsequent dementia (OR 0.95 (0.91,
1.00), p = 0.04).
Cox regression analyses (Table 2)
In both Cox regression models, APOE ɛ4 continued to
be an important predictor for dementia (Cox model 2:
Hazard Ratio (HR) 2.85 (95% confidence interval: 1.85,
4.41), p < 0.001). The results did however demonstrate
that once death was considered within the analyses, the
association between FEV1 and dementia did not reach
statistical significance in either model (Cox model 2: HR
1.30 (0.74, 2.30), p = 0.37). Neither grip strength (Cox
model 2: HR 0.98 (0.94, 1.02), p = 0.35) nor walking
speed (Cox model 2: HR 0.99 (0.87, 1.13), p = 0.90) was
associated with dementia in either model. No other vari-
able was demonstrated to be associated with dementia.
Cumulative incidence graphs
For the purposes of calculating cumulative incidence,
FEV1 results were divided into two groups, at a value of
1.8 l per second. This value was close to both the sample
mean and median. The stacked cumulative incidence
plot shown in Fig. 1 demonstrated that increased FEV1
was associated with decreased risk of death but not
dementia (Fig. 1). A second cumulative incidence plot
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confirmed that the presence of an APOE ɛ4 allele was
associated with an increased risk for dementia (Fig. 2).
Discussion
Contrary to the existing evidence within the literature
[2–15], this study found that decreased fitness beyond
age 79 was not a risk factor for subsequent dementia.
More specifically, FEV1, grip strength and walking
speed at age 79 years were not found to be associated
with dementia. Indeed, considering those who survive,
greater FEV1 is associated with an increased risk of
dementia: that is, if you survive, having better respira-
tory function (a measure of fitness) when you are
younger makes it more likely that you will develop
dementia. Even when the effect of poor respiratory
function on mortality risk is taken into account, being
fitter as a younger adult does not confer any benefit
with regards to dementia risk once you reach your
ninth decade. This raises an important distinction be-
cause better physical fitness was associated with
higher cognitive scores in oldest age, even after
adjusting for childhood IQ, in this same cohort [1].
That is, having better physical fitness at age 79 was
good for a person’s cognitive ability but did not re-
duce the risk of developing dementia. As was ob-
served in a previous study of the LBC1921, the
presence of an APOE ɛ4 allele was however associated
with an increased risk for dementia [29].
Table 1 Study Sample Demographics and Group Comparison
Eligible Participants (n = 488) Group Comparison p value
(chi-square or t-test)
Excluded Participants
(n = 62)Dementia (n = 109) No Dementia (n = 379)
Age n = 109 n = 379 n = 62
-mean age in years (SD) 79.04 (0.55) 79.08 (0.59) 0.54 79.09 (0.53)
Sex n = 109 n = 379 n = 62
-% female 62.4% 55.9% 0.23 58.1%
Living or deceased n = 109 n = 379 n = 62
-% deceased 80.7% 83.3% 0.08 29.0%
MMSE score at baseline n = 109 n = 379 n = 60
-mean score (SD) 28.10 (1.64) 28.33 (1.46) 0.16 27.27 (2.67)
Height n = 106 n = 378 n = 60
-Mean height in cm (SD) 162.11 (9.21) 163.59 (9.45) 0.15 163.83 (8.53)
APOE ɛ4 carrier status n = 109 n = 373 n = 61
-% carrier APOE ɛ4 41.3% 22.5% < 0.001 27.4%
Age 11 IQ (standardised) n = 101 n = 339 n = 53
-Mean score (SD) 100.19 (16.18) 100.22 (14.53) 0.98 98.21 (15.63)
FEV1 n = 106 n = 378 n = 60
-mean rate in litres per second (SD) 1.95 (0.59) 1.84 (0.62) 0.12 2.03 (0.68)
Grip strength n = 106 n = 378 n = 60
-mean strength in kilograms (SD) 25.89 (10.17) 26.46 (8.87) 0.57 28.18 (8.59)
6 m walk time n = 105 n = 377 n = 59
-mean time in seconds (SD) 4.56 (1.53) 4.84 (2.11) 0.20 4.37 (1.29)
Smoking status n = 108 n = 379 n = 62
-% ever smoker 42.6% 61.7% < 0.001 50.0%
History of cardiovascular or cerebrovascular disease n = 104 n = 373 n = 58
-% positive history 28.9% 28.2% 0.89 24.2%
History of hypertension n = 108 n = 375 n = 61
-% positive history 35.2% 41.9% 0.21 41.0%
History of diabetes n = 109 n = 379 n = 62
-% positive history 4.6% 5.8% 0.62 1.6%
Italicized results demonstrate significance of p<0.05
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Table 2 Regression Results
Odds/ Hazard Ratios (95% CI) for Probable Dementia
Logistic Regression
Model 1
Cox Regression
Model 1
Logistic Regression
Model 2
Cox Regression
Model 2
Odds Ratios
(95% CI)
Hazard Ratios
(95% CI)
Odds Ratios
(95% CI)
Hazard Ratios
(95% CI)
(n = 425) (n = 425) (n = 416) (n = 416)
Sex (female) 0.77 (0.31, 1.85) 1.26 (0.56, 2.83) 0.86 (0.34, 2.11) 1.42 (0.63, 3.23)
Age (days) 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
Height (centimetres) 0.96 (0.92, 1.00) 0.97 (0.94, 1.01) 0.95 (0.91, 1.00) 0.97 (0.93, 1.01)
APOE ɛ4 carrier 2.47 (1.49, 4.08) 2.72 (1.78, 4.14) 2.52 (1.50, 4.22) 2.85 (1.85, 4.41)
Age 11 IQ 1.00 (0.98, 1.02) 0.99 (0.98, 1.01) 1.00 (0.98, 1.02) 1.00 (0.98, 1.01)
History of hypertension 0.64 (0.38, 1.05) 0.79 (0.51, 1.23) 0.64 (0.38, 1.06) 0.78 (0.50, 1.22)
Smoker (ever) 0.63 (0.38, 1.04) 0.92 (0.60, 1.40) 0.62 (0.37, 1.03) 0.94 (0.61, 1.45)
FEV1 (l/s) 2.05 (1.15, 3.75) 1.43 (0.82, 2.48) 1.93 (1.07, 3.57) 1.30 (0.74, 2.30)
6 m walk time (s) 0.93 (0.79, 1.07) 0.99 (0.87, 1.13) 0.94 (0.79, 1.08) 0.99 (0.87, 1.13)
Grip strength (kg) 1.00 (0.96, 1.05) 0.98 (0.94, 1.02) 1.01 (0.96, 1.05) 0.98 (0.94, 1.02)
History of cardiovascular or cerebrovascular
disease
– – 1.08 (0.61, 1.86) 1.14 (0.72, 1.81)
History of diabetes – – 0.86 (0.19, 2.88) 1.39 (0.41, 4.66)
Logistic regression model 1 and Cox regression model 1: included FEV1, grip strength, 6-m walk time, APOE ɛ4 carrier status, height, age, sex, history of
hypertension, smoking status and age 11 IQ, with the development of probable dementia as the outcome. Logistic regression model 2 and Cox regression model
2: as logistic regression model 1 plus history of cardiovascular or cerebrovascular disease and history of diabetes. Results for Cox regressions show the hazard
ratios and 95% confidence intervals. Statistically significant results are italicized
Fig. 1 Cumulative incidence of dementia and death (stacked) at 2 levels of FEV1. Note. FEV1 groups were split at 1.8 l per second
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Previous studies have repeatedly shown that poorer
lung function, grip strength and walking speed are asso-
ciated with increased risk for dementia [2–15]. The pri-
mary reason for this inconsistency may be that most
previous studies have investigated the association in a
younger population, or a population with a broader age
range than the LBC1921 [2, 7]; the results of this study
may differ simply because the results are specific to the
oldest-old. We might also consider the impact of death
on our finding. In our cohort, increased lung function at
age 79 was associated with a reduce risk of death. We
can therefore hypothesize that our null findings may be
due to the fact that those with poorer fitness, who would
have been more likely to develop dementia, would have
died from another cause before developing dementia.
Taking lung function as an example, in addition to death
directly related to lung disease, death before dementia
may occur because of diabetes, atherosclerosis or coronary
heart disease, all of which are known to be associated with
poorer lung function [5]. Given that our competing risks
analyses accounts for this possibility, we would not expect
to have found an increased risk of dementia for those with
low FEV1 if these people had survived.
In examining the potential influences on our findings
it is worthwhile considering the fitness levels of the par-
ticipants of the study, when compared with population
norms. While predicted values for FEV1 are less well
established for those aged over 70 years, formulae
published by the British Thoracic Society can be used to
calculate the expected results for our study population
[28]. Females included in our study achieved, an average,
94.5% of the predicted FEV1 value, while males achieved
88.8% of the predicted value, based on mean age and
height. Both of these were above the 80% cut-off used to
demonstrate abnormality, and below the 100% threshold
that would demonstrate better than expected lung function.
The mean walking speed recorded for male and female
study participants (137 cm per second and 118 cm per sec-
ond, respectively) were similar to published normative
values for persons aged in their 70s (133 cm per second
and 127 cm per second for males and females respectively)
[35]. Previously published expected median values for grip
strength – measured using a Jamar Hydraulic Hand
Dynamometer – also closely resemble those achieved in
the present study [36]. For males, the expected median
was 34.9 kg, and the achieved median and mean were
34 kg and 34.5 kg respectively. For females, the ex-
pected median was 20.9 kg, and the achieved median
and mean were 20 kg and 20.3 kg respectively. One
might expect the values for grip strength and walking
speed to be slightly below expected levels because the
reference values were for individuals aged 70–79 years
and the participants of this study were at the upper-
most limit of this age bracket. Based on these results
one might assume that, with respect to grip strength,
walking speed and FEV1, this study cohort were not
Fig. 2 Cumulative incidence of dementia for APOE ɛ4 carriers and non-carriers. Note. Predicted cumulative incidence of dementia (Aalen-Johansen
estimator) for men aged 79 of average height, fitness (FEV, 6 m walking time, and grip strength), and age 11 IQ
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of unusually high or low fitness and reflected a typ-
ical population of this age.
It is also possible that the lack of association observed
in our results is the result of some type of resilience to
disease. It is acknowledged within the literature that
some individuals do not appear to be susceptible to the
negative effects of certain lifestyle habits. For example,
some heavy smokers do not develop lung disease [37].
Studies – including a large Medical Research Council
funded study of UK Biobank data – have suggested that
DNA variants may explain why some individuals can have
relatively good lung health despite smoking [38, 39]. It is
possible that there is a similar unidentified genetic resili-
ence for dementia, such that those who are more suscep-
tible to developing dementia because of certain risk
factors will do so prior to oldest age, while those who are
genetically resilient will continue to be resilient in oldest
age, resulting in a lack of observed association.
The null findings of this study should not be overlooked
as unimportant. If these associations are indeed only
present in earlier old age, the fact that lung function, grip
strength and walking speed were not significantly associ-
ated with dementia in our cohort, demonstrates an
important difference between the risk profile for dementia
in early old age and late old age.
Since the median age of dementia diagnosis in the UK,
for example, is now over 80, if our findings are repli-
cated, it means that for the majority of people who will
develop dementia seeking to improve physical fitness is
unlikely to have any effect on preventing the disease.
Although our findings do not concur with previous re-
ports, our findings are supported by other health-related
analyses in this cohort that identified changes in the risk
factor profile for dementia in advanced old age [29]. In
the LBC1921, a history of hypertension was associated
with a decreased risk of dementia, and increased phys-
ical activity in early adulthood was associated with an in-
creased risk for dementia after age 79 years [29].
Whereas the relationship between physical activity and
dementia was novel, other studies have described a change
in the relationship between hypertension and dementia in
the oldest old [40]. The results of the present study,
together with these previous findings, would indicate that
there is different risk profile for dementia in the oldest
old, when compared with those in earlier old age.
Our findings therefore highlight two important differ-
ences. Firstly, it seems increasingly likely that the risk
profile for dementia in oldest age differs from the risk
profile in earlier old age. Secondly, that the risk profile for
dementia in oldest age differs from the risk profile for less
successful non-pathological cognitive ageing in the oldest
old. Understanding the risk profiles for each of these
separate processes and how they differ is important, as
this knowledge will aid in the design and development of
appropriate prevention and management strategies. Given
that dementia is set to be one of the greatest public health
challenges facing the ageing population, successful
cost-effective prevention strategies are of vital importance.
Strengths and limitations
A significant strength of this study lies in the suitability of
the cohort for these analyses. The minimal cultural, ethnic
and geographical variability within the narrow-age cohort
minimises confounding errors and means that the results
are specific to the oldest old. We recognise, though, that
this limits the generalisability of the results, and so
additional studies are required in other groups. The avail-
ability of a childhood IQ score is a rare strength of the
study, as is the detailed follow-up completed since enrol-
ment in the study. The high mean baseline MMSE score
(28.3, SD: 1.5) for those included in the analyses increases
the likelihood that we identified incident cases of demen-
tia, rather than prevalent cases. By including multiple
measures of fitness it was possible to consider several
components of fitness. Whilst this was a strength of our
study, it could be argued that additional tests could have
provided a more comprehensive assessment of fitness. We
selected the additional variables for inclusion in the ana-
lyses based on the available evidence, but it is possible that
there was some residual confounding due to a variable not
considered in this study. It is not however possible to
exclude all such possibilities without negatively affecting
the analyses through multiple hypotheses testing. The
dementia ascertainment method in this study has previ-
ously been shown to be effective and comparable with
expected rates [29]. Having determined dementia cases
retrospectively using existing data, it was not possible to
accurately date the onset of dementia. For this reason, we
cannot be entirely confident in the accuracy of the time to
dementia variable. The method used to determine date of
onset in this study, is however conservative and it is likely
that dementia onset preceded our assigned date by some
time. As such, the true competing risk of death is almost
certainly less than we are adjusting for in the model.
While we recognise this limitation of our study, it is not
unique to our method; it is notoriously difficult to pin-
point the exact date of dementia onset, even in studies
using prospective clinical follow-up. This is particularly
true given that the most common form of dementia –
Alzheimer’s disease – has a gradual onset. A further limi-
tation of our study is the possibility of missed cases. Our
results could also have been affected by using an outcome
of probable dementia of any subtype. The number of
participants with each subtype of dementia was too few to
perform individual analyses. It is also possible that the
overall size of our study cohort had an impact on our find-
ings, and that a larger sample size would have produced
differing results.
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Conclusions
The results of this study suggest that increased physical
fitness at age 79 years does not reduce the risk for subse-
quent dementia. The early death of participants with
poorer fitness, who would have been more at risk of
dementia dying before developing dementia, might explain
why the findings differ from studies of earlier old age.
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